Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Research article

Differential expression of a new isoform of DLG2 in renal oncocytoma

Dmitry Zubakov, Zorica Stupar and Gyula Kovacs*

Author Affiliations

Laboratory of Molecular Oncology, Medical Faculty, Ruprecht-Karls-University, Heidelberg, Germany

For all author emails, please log on.

BMC Cancer 2006, 6:106  doi:10.1186/1471-2407-6-106

Published: 26 April 2006

Abstract

Background

Renal oncocytoma, a benign tumour of the kidney, may pose a differential diagnostic problem due to overlapping phenotype with chromophobe renal cell carcinoma or other types of renal cell tumours. Therefore, identification of molecular markers would be of great value for molecular diagnostics of this tumour type.

Methods

In the current study we applied various techniques, including Affymetrix microarray hybridization and semiquantitative RT-PCR, to identify genes expressed differentially in renal oncocytomas. Subsequently, we used RACE and Northern blot hybridization to characterize the potential candidates for molecular diagnosis.

Results

We have identified new isoform of DLG2 gene, which contains 3'-end exons of the known DLG2 gene along with the hypothetical gene FLJ37266. The new isoform is specifically upregulated in renal oncocytoma, whereas the known DLG2 gene is downregulated in this type of kidney tumour.

Conclusion

The new isoform of DLG2 is the promising candidate gene for molecular differential diagnostics of renal oncocytoma.